Clinical pattern of checkpoint inhibitor-induced liver injury in a multicentre cohort
JHEP Reports · 2023-06 · 5 (6) · 100719
DOI: 10.1016/j.jhepr.2023.100719 ↗Kurz gefasst
Fachartikel in der Zeitschrift JHEP Reports, 2023-06. Verfasst von Lina Hountondji und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Liver Transplantation, Saint Eloi Hospital, Montpellier University Hospital, Montpellier, France. Die Arbeit wurde bisher 79-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background & Aims: Immune checkpoint inhibitors (ICIs) have changed the landscape of cancer therapy. Liver toxicity occurs in up to 25% of patients treated with ICIs. The aim of our study was to describe the different clinical patterns of ICI-induced hepatitis and to assess their outcome. Methods: We conducted a retrospective observational study of patients with checkpoint inhibitor-induced liver injury (CHILI) discussed in multidisciplinary meetings between December 2018 and March 2022 in three French centres specialised in ICI toxicity management (Montpellier, Toulouse, Lyon). The hepatitis clinical pattern was analysed by the ratio of serum alanine aminotransferase (ALT) and alkaline phosphatase (ALP) (R value = (ALT/ULN)/(ALP/ULN)) for characterisation as cholestatic (R ≤2), hepatocellular (R ≥5), or mixed (2
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Liver Transplantation, Saint Eloi Hospital, Montpellier University Hospital, Montpellier, France.
- Department of Internal Medicine, IUCT-Oncopole, Toulouse University Hospital, Toulouse, France.
- Department of Hepatology, Croix Rousse Hospital, Lyon Liver Institute, Hospices Civils of Lyon, Lyon, France.
- Department of Medical Oncology, Montpellier Cancer Institute, Montpellier University Hospital, Montpellier, France.
- Department of Dermatology, Saint Eloi Hospital, Montpellier University Hospital, Montpellier, France.
- Department of Medical Pharmacology and Toxicology, Lapeyronie Hospital, Montpellier University Hospital, Montpellier, France.
Zitieren
APA
Hountondji, L., Ferreira De Matos, C., Lebossé, F., Quantin, X., Lesage, C., Palassin, P., Rivet, V., Faure, S., Pageaux, G. P., Assenat, É., Alric, L., Zahhaf, A., Larrey, D., Witkowski Durand Viel, P., Riviere, B., Janick, S., Dalle, S., Maria, A. T. J., Comont, T., & Meunier, L. (2023). Clinical pattern of checkpoint inhibitor-induced liver injury in a multicentre cohort. JHEP Reports, 5(6), 100719. https://doi.org/10.1016/j.jhepr.2023.100719
Vancouver
Hountondji L, Ferreira De Matos C, Lebossé F, Quantin X, Lesage C, Palassin P, et al. Clinical pattern of checkpoint inhibitor-induced liver injury in a multicentre cohort. JHEP Reports. 2023;5(6):100719. doi:10.1016/j.jhepr.2023.100719
BibTeX
@article{Hountondji2023,
author = {Hountondji, Lina and Ferreira De Matos, Christophe and Lebossé, Fanny and Quantin, Xavier and Lesage, Candice and Palassin, Pascale and Rivet, Valérian and Faure, Stéphanie and Pageaux, Georges-Philippe and Assenat, Éric and Alric, Laurent and Zahhaf, Amel and Larrey, Dominique and Witkowski Durand Viel, Philine and Riviere, Benjamin and Janick, Selves and Dalle, Stéphane and Maria, Alexandre Thibault Jacques and Comont, Thibaut and Meunier, Lucy},
title = {Clinical pattern of checkpoint inhibitor-induced liver injury in a multicentre cohort},
journal = {JHEP Reports},
year = {2023},
volume = {5},
number = {6},
pages = {100719},
doi = {10.1016/j.jhepr.2023.100719}
}
EUVIMED